Literature DB >> 10393213

Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1.

B Gauthier1, M Robb, F Gaudet, G S Ginsburg, R McPherson.   

Abstract

Cholesteryl ester transfer protein (CETP) is expressed in human adipocytes, where it acts to promote selective uptake of HDL-CE (Benoist, F., M. McDonnell, P. Lau, R. Milne, and R. McPherson. 1997. J. Biol. Chem. 272: 23572;-23577). In contrast to other major sterol-responsive genes such as 3-hydroxy-3-methylglutaryl coenzyme A reductase CETP expression is up-regulated rather than down-regulated in response to cholesterol. To define elements involved in cholesterol-mediated up-regulation of CETP gene expression, deletion derivatives of the CETP promoter were cloned into a luciferase reporter construct and transfected into the human liposarcoma cell line SW872, cultured in the presence or absence of lipoproteins. A fragment associated with a positive cholesterol response was identified between nucleotides -361 and -138 (relative to the initiation site of transcription) of the promoter. This region contains a tandem repeat of a sequence known to mediate sterol dependent regulation of the hamster HMG-CoA reductase gene. We have putatively denoted this region, the cholesterol response element (CRE). Using gel mobility shift assays we demonstrate that both YY1 and SREBP-1 interact with the CRE of CETP. Furthermore, in transient co-transfection experiments, both YY1 and SREBP-1a were found to trans-activate, in a dose-dependent manner, the luciferase activity of constructs harboring the CRE. We also demonstrate that SREBP-2, is able to trans-activate a luciferase construct harboring the CRE although much less effectively as compared to SREBP-1. Finally, functional analysis of the CRE confirms its regulatory role in modulating CETP gene expression through its interaction with YY1 and SREBP-1a.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393213

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Peripheral vascular atherosclerosis in a novel PCSK9 gain-of-function mutant Ossabaw miniature pig model.

Authors:  Ahmad F Hedayat; Kyoung-Ha Park; Taek-Geun Kwon; John R Woollard; Kai Jiang; Daniel F Carlson; Amir Lerman; Lilach O Lerman
Journal:  Transl Res       Date:  2017-11-03       Impact factor: 7.012

2.  Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice.

Authors:  Thomas Gautier; Willeke de Haan; Jacques Grober; Dan Ye; Matthias J Bahr; Thierry Claudel; Niels Nijstad; Theo J C Van Berkel; Louis M Havekes; Michael P Manns; Stefan M Willems; Pancras C W Hogendoorn; Laurent Lagrost; Folkert Kuipers; Miranda Van Eck; Patrick C N Rensen; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2013-04-25       Impact factor: 5.922

3.  Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter.

Authors:  S Santamarina-Fojo; K Peterson; C Knapper; Y Qiu; L Freeman; J F Cheng; J Osorio; A Remaley; X P Yang; C Haudenschild; C Prades; G Chimini; E Blackmon; T Francois; N Duverger; E M Rubin; M Rosier; P Denèfle; D S Fredrickson; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

4.  Regulation by long-chain fatty acids of the expression of cholesteryl ester transfer protein in HepG2 cells.

Authors:  R Hirano; O Igarashi; K Kondo; H Itakura; A Matsumoto
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

5.  ATF6 modulates SREBP2-mediated lipogenesis.

Authors:  Lingfang Zeng; Min Lu; Kazutoshi Mori; Shengzhan Luo; Amy S Lee; Yi Zhu; John Y-J Shyy
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

6.  Association study of promoter polymorphisms in the CETP gene with longevity in the Han Chinese population.

Authors:  Jian-Kang Yang; Yuan-Ying Gong; Liang Xie; Ya Yang; Liang-You Xu; Ya-Ping Zhang
Journal:  Mol Biol Rep       Date:  2013-11-17       Impact factor: 2.316

7.  Protective effects of the imidazoline-like drug lnp599 in a marmoset model of obesity-induced metabolic disorders.

Authors:  Maud Weiss; Lyne Fellmann; Pierrick Regnard; Pascal Bousquet; Laurent Monassier; Nathalie Niederhoffer
Journal:  Int J Obes (Lond)       Date:  2021-03-02       Impact factor: 5.095

8.  The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets.

Authors:  Thierry Brun; Isobel Franklin; Luc St-Onge; Anna Biason-Lauber; Eugene J Schoenle; Claes B Wollheim; Benoit R Gauthier
Journal:  J Cell Biol       Date:  2004-12-13       Impact factor: 10.539

Review 9.  Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Authors:  M John Chapman; Wilfried Le Goff; Maryse Guerin; Anatol Kontush
Journal:  Eur Heart J       Date:  2009-10-12       Impact factor: 29.983

10.  Mixed modeling of meta-analysis P-values (MixMAP) suggests multiple novel gene loci for low density lipoprotein cholesterol.

Authors:  Andrea S Foulkes; Gregory J Matthews; Ujjwal Das; Jane F Ferguson; Rongheng Lin; Muredach P Reilly
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.